Objective: To describe the long-term audiologic findings in pediatric patients with enlarged vestibular aqueducts (EVAs). The relationship between the hearing loss (HL) and the dimensions of the EVA, enlarged endolymphatic duct (EED), or enlarged endolymphatic sac (EES) was also investigated. The influence of a Pendred syndrome (PS) diagnosis on the audiologic phenotype was also examined. Study Design: Retrospective analysis of case notes and imaging records, including measurement of the dimensions of the EVA, EED, and EES. Setting: Tertiary referral center. Patients: Twenty-seven patients (21 female, 6 male) had an EVA in at least one ear. Eightyfive percent had bilateral enlargements. Median age at onset of follow-up was 5.0 years, and median follow-up was 9.7 years. Main Outcome Measures: Hearing thresholds at the start and end of follow-up, rate of progression of HL, history of sudden drops in hearing. Results: All ears with an EVA had HL. Average HL at the start and end of follow-up was severe. Thirty-seven percent of patients had progressive HL, and 33% reported sudden drops in hearing. Progression was significantly associated with a history of sudden drops. PS patients had worse hearing at the end of follow-up as compared with nonsyndromic patients. There was no evidence of a relationship between the dimensions of the EVA, EED, or EES and the severity or progression of HL. Conclusions: Patients with EVAs should be advised to avoid known trigger factors for sudden drops in hearing (e.g., minor head trauma). A diagnosis of PS may be associated with a worse audiologic prognosis.
INTRODUCTION
The vestibular aqueduct (VA) is a bony channel in the petrous temporal bone that contains a narrow, tubular component of the membranous labyrinth known as the endolymphatic duct (ED). The ED originates opposite the medial wall of the vestibule and runs posterolaterocaudally to expand distally into the blind-ending extraosseous endolymphatic sac (ES). 1 The ES lies alongside the posterior fossa within a duplication of the dura. The ED and ES are thought to function as a metabolically active filter that regulates endolymph volume and composition. 2 The advent of computerized tomography of the petrous temporal bones (CT PT) demonstrated that enlarged VAs (EVAs) are a common finding in children with significant, permanent hearing loss (HL). [3] [4] Approximately 10% have EVAs, making this the most prevalent radiologically detectable inner ear abnormality in these children. [5] [6] [7] The enlargements are bilateral in approximately 80% of patients. 8 Magnetic resonance imaging of the internal acoustic meati (MRI IAM) demonstrates that most ears with an EVA have an associated enlarged ED (EED) and sac (EES). 9 Additional inner ear abnormalities are often found on imaging, with deficiency of the interscalar septum between the cochlear apical and middle turns and a dilated vestibule being most commonly reported. 10 A proportion of EVA patients have an associated thyroid iodine organification defect, which typically results in goitre and hypothyroidism in the second decade. This combination of thyroid dysfunction and EVAs is termed Pendred syndrome (PS). PS is an autosomal recessive condition caused by biallelic mutations in the solute carrier 26, member A4 (SLC26A4 [Pendrin]) gene. 11 Before SLC26A4 identification, PS was diagnosed with the perchlorate discharge test (PDT). The PDT involves quantifying the level of thyroid discharge of radioisotope- Send correspondence to Dr. I. B. Colvin, Flat 5, 100 Drayton Park, Highbury, London, N5 1NF, England. E-mail: ian.colvin@blueyonder.co.uk labeled iodide in response to an oral or intravenous perchlorate challenge. PS patients have characteristically high levels of discharge, irrespective of their clinical thyroid status. 11 HL associated with EVAs is predominantly sensorineural, with a low frequency conductive component. 12 It is usually detected in early childhood, is bilateral, predominantly affects higher frequencies, and ranges from mild to profound in severity. 13, 14 Progression of HL is recognized in a proportion of patients. 13, 14 Sudden drops in hearing, often triggered by minor head trauma, followed by complete or nearcomplete recovery, are a characteristic feature. 2, 13 Given the paucity of literature regarding the HL prognosis, the aim of this study is to report the longitudinal audiologic findings in pediatric EVA patients. In addition, this study will examine whether there is any relationship between the audiologic findings and the dimensions of the EVA, EED, or EES. The influence of a PS diagnosis on the audiologic phenotype will also be examined.
MATERIALS AND METHODS

Study Design and Patient Inclusion Criteria
The study design was a retrospective analysis of case notes and imaging records of patients who had attended a pediatric audiovestibular medicine clinic at the Royal National Throat, Nose and Ear Hospital (RNTNEH), United Kingdom, between 1990 and 2005. Inclusion criteria were an EVA or EED in at least one ear (according to criteria defined anon in the article) and at least three audiograms in the case notes, with a minimum 1 year interval between the first and last audiogram.
Radiologic Data Collection
CT PT films were obtained if available. The maximum midpoint diameter (MMD) of each VA was obtained by measuring its width at a point halfway between the common crus and the external aperture on axial images (Fig. 1) . 2, 8, 14 Measurements were taken with a calibrated jeweller's eyepiece. Most plain film images were reproduced at a reduced scale, and measurements were therefore multiplied by an appropriate factor to convert back to patient dimensions. A small number of films without a printed caliper to indicate the scale of reduction could not be measured.
MRI IAM had been undertaken with a 1.5 T scanner. Axial images had been obtained using a T2-weighted spin-echo sequence with 1.4 mm slice thickness and 0.7 mm slice overlap. Digital MRIs were measured using DicomWorks PC software (version 1.3.5). The MMD of each ED was measured at an equivalent position to the MMD on CT PT (Fig. 2) . The ES maximum anteroposterior and transverse diameters and maximum crosssectional area were also measured (Fig. 3) . If digital images were not available, plain films were measured with the jeweller's eyepiece. Cross-sectional area was not measurable by hand. All measurements were undertaken separately by two investigators (I.C. and T.B.). T.B. also examined all imaging for additional inner ear abnormalities.
CT PT or MRI IAM reports were obtained for patients for whom films or digital images were unavailable or not measurable. Reports had been generated by RNTNEH radiologists, all of whom were experienced in diagnosing inner ear dysmorphology.
Study Criteria for Enlarged Vestibular Aqueduct or Enlarged Endolymphatic Duct
Previous studies that have used MMD to define an EVA or EED have used an upper limit of normal of between 1.4 and 2.0 mm. 2, 5, [13] [14] [15] [16] Criteria in the current study (Table I) were designated to ensure that enlargements were definite, with equivocal enlargements excluded.
Audiology Data Collection
Each patient's history of HL was recorded, including progression, sudden drops, triggers for sudden drops, and any additional risk factors for permanent HL (Table II) . Results of all behavioral hearing tests that provided reliable separate ear thresholds were recorded. The majority of these tests were puretone audiograms. Air and bone conduction thresholds at 250, 500, 1,000, 2,000, and 4,000 Hz were recorded. For each audiogram, a mean auditory threshold (MAT) for each ear was calculated by averaging the five air conduction thresholds. Tympanometry results at the time of each audiogram were recorded. Normative values for tympanometry used in the study were middle ear pressure Ϫ150 to ϩ50 daPA and admittance 0.3 to 1.6 cm 3 . 17 To control for the confounding effect of commonly acquired pediatric middle ear conditions (e.g., chronic serous otitis media with effusion [CSOME]) on the hearing analysis, adjustments were made to each MAT according to the tympanometry. If tympanometry demonstrated a middle ear effusion (i.e., admittance Ͻ0.3 cm 3 , middle ear pressure unrecordable, normal ear canal volume), the MAT was adjusted by Ϫ10 dB. This was a conservative adjustment based on previous work demonstrating a 17 dB mean airbone gap in CSOME. 18 If tympanometry indicated negative middle ear pressure (i.e., normal admittance, middle ear pressure Ͻ150 daPA), the MAT was adjusted by -5 dB. Evidence of a patient having a nonacquired conductive component (NACC) to their HL was defined as evidence of an air-bone gap more than 10 dB at one or more frequencies in at least one ear on at least one audiogram in conjunction with normal tympanometry in the affected ear/ears at the time of the audiogram.
To assess for HL progression, univariate linear regression analysis was performed using time elapsed since the first audiogram (in years) as the input variable and MAT as the output variable. The regression line slope therefore represented an estimate of the average yearly change in MAT. Criteria used to define progressive HL (PHL) are shown in Table III .
Pendred Syndrome
SLC26A4 mutation testing and PDT results were recorded when available. Study criteria for PS or nonsyndromic EVAs (NSEVAs) were based on recent genotype/phenotype evidence (Table IV) . 11 
TABLE II. Risk Factors for Additional Hearing Loss.
Maternal infection in pregnancy with cytomegalovirus, toxoplasmosis, rubella, HIV, or varicella zoster virus History of preterm delivery (Ͻ37 wk completed gestation) 19 Low birth weight (Ͻ2,500 g) 19 Significant birth trauma (e.g., hypoxia requiring resuscitation)
Period of Ͼ3 days on neonatal intensive care unit after birth EVA ϭ enlarged vestibular aqueduct; CT PT ϭ computerized tomography of petrous temporal bones; EED ϭ enlarged endolymphatic duct; MRI IAM ϭ magnetic resonance imaging of internal acoustic meati; MMD ϭ maximum midpoint diameter; EES ϭ enlarged endolymphatic sac; VA ϭ vestibular aqueduct; ED ϭ endolymphatic duct; RNTNEH ϭ Royal National Throat, Nose and Ear Hospital.
Data Analysis
Data analysis was performed using SPSS for Windows (release 11.0.0, Chicago, IL).
RESULTS
Sample and Audiologic Follow-up Details
Twenty-seven patients (21 female, 6 male) met the inclusion criteria. Twenty-three (85%) had bilateral EVAs or EEDs, and four (15%) had unilateral enlargements, resulting in 50 affected ears in the study sample. One bilateral patient only had unilateral follow-up audiometry as the first hearing test had demonstrated unrecordable thresholds in the other ear (i.e., a "dead" ear). This ear without follow-up was excluded from study analysis. The median age of patients at the first audiogram was 5.0 (mean, 5.7; range, 2.7-10.9) years, and median age at the last audiogram was 17.0 (mean, 15.3; range, 7.2-26.9) years. The median length of audiologic follow-up was 9.7 (mean, 9.6; range, 1.4 -22.1) years. The median number of audiograms for each ear was 15 (mean, 15; range, .
One patient's mother had a bilateral, moderate sensorineural HL. Otherwise, no patient had additional risk factors for permanent HL.
Audiologic Follow-up Results
The average MAT scores at the start and end of follow-up are shown in Table V and Figure 4 . Sixteen (33%) ears had PHL. For ears with PHL, the median rate of progression was 2.1 (mean, 3.0; range: 0.7-7.9) dB per year. Ten (37%) patients had PHL in at least one ear. 
Sudden Drops in Hearing
A history of the presence or absence of sudden drops was available for all patients. Nine (33%) had sudden drops. Seven (78%) of the nine patients reported a trigger factor on at least one occasion. All seven reported minor Table VI. 2 testing demonstrated evidence of an association between sudden drops and PHL in at least one ear (P ϭ .02). Patients with sudden drops had a relative risk of 3.0 (95% confidence interval [CI]: 1.1-8.0) for having PHL in at least one ear. †MAT score averaged between both ears for patients with bilateral EVAs/EEDs; MAT from affected ear only if unilateral EVA/EED. MAT ϭ mean auditory threshold; PHL ϭ progressive hearing loss; NSEVAs ϭ nonsyndromic enlarged vestibular aqueducts; EVAs ϭ enlarged vestibular aqueducts; EEDs ϭ enlarged endolymphatic ducts; EVA ϭ enlarged vestibular aqueduct; EED ϭ enlarged endolymphatic duct.
Nonacquired Conductive Component to Hearing Loss
Fifteen patients had data from tympanometry and audiometry to allow assessment for the presence or absence of a NACC to their HL. Twelve (80%) had a NACC. The magnitude of the air-bone gap was measurable in 10 ears that had masked bone conduction thresholds recorded on at least one audiogram (Table VII) .
Pendred Syndrome
Six (22%) patients had PS, 13 (48%) had NSEVAs, and syndromic status was unknown for 8 (30%). A comparison of hearing for PS and NSEVAs patients is shown in Table VI. 2 testing did not demonstrate an association between PS and PHL at either an ear (P ϭ .18) or patient level (P ϭ .24). However, there was an association between PS and a history of sudden drops ( 2 testing: ear level P ϭ .00; patient level P ϭ .01). The relative risk of sudden drops for PS patients was 8.7 (95% CI: 1.2-61.9).
Radiology Results
Twenty-two patients had undergone CT PT, and measurable films were available for 11. Three had a unilateral EVA, thereby resulting in 19 measurable EVAs. A CT PT report confirming EVAs was available for the 11 patients without measurable films.
Nineteen patients had undergone MRI IAM, and digital image files were available for 18. Measurable films were available for the other patient. Thirteen had bilaterally EEDs and EESs, two had a unilateral EED and EES, two had bilaterally EEDs but no EESs, and two had an EED and EES in one ear and an EED with no EES contralaterally. One patient with bilaterally EEDs and EESs had one ear without audiologic follow-up excluded from analysis, resulting in 35 measurable EEDs and 29 measurable EESs.
All VA/ED/ES measurements were highly correlated between the two investigators (Spearman's correlation: r Ͼ 0.8, P Ͻ .01). There were no significant differences between investigator means for CT MMD, MRI MMD, maximum anteroposterior diameter, or maximum transverse diameter (Wilcoxon signed-rank test: P Ͼ .05). Mean maximum cross-sectional area was significantly different between the investigators (P ϭ .02), but the difference was small (I.C. median, 5.5 mm 2 ; T.B. median, 5.4 mm 2 ). The mean of both investigator measurements was therefore used for study analysis. A summary of the measurements is shown in Table VIII . Thirteen ears had MMD data from CT and MRI; MMD scores were highly correlated between the two modalities (Spearman's correlation: r ϭ 0.74, P ϭ .00), with no significant difference between means on Wilcoxon signed-rank testing.
Six (22%) patients had additional inner ear abnormalities. All additional abnormalities were bilateral, although one patient had a unilateral EVA. Therefore 11 (22%) of the EVA ears had an additional abnormality. The abnormalities were a deficiency of the interscalar septum between the cochlear apical and middle turns in four patients (8 ears), dilated vestibules in one patient (two ears), and both abnormalities in one patient (2 ears).
Relationship Between Radiologic and Audiologic Findings
There was no evidence of correlation between hearing at the start and end of follow-up and any of the VA/ED/ES measurements (Table IX) . There was no strong evidence that PS, PHL, or sudden drops were associated with significant differences in VA/ED/ES measurements (Table X) .
There were no significant differences between average MAT scores at the start and end of follow-up for ears with or without additional inner ear abnormalities.
2 testing did not demonstrate evidence of a relationship between additional inner ear abnormalities and PS, PHL, or sudden drops. CT PT ϭ computerized tomography of the petrous temporal bones; VA ϭ vestibular aqueduct; MRI IAM ϭ magnetic resonance imaging of the internal acoustic meati; ED ϭ endolymphatic duct; ES ϭ endolymphatic sac.
DISCUSSION
Other than the very first EVA sample reported by Valvassori, 4 this study provides the largest reported sample of patients with definite EVAs (i.e., MMD Ͼ1.4 mm). Furthermore, this sample has the longest follow-up period of any EVA hearing study. The study female to male ratio CT PT ϭ computerized tomography of petrous temporal bones; VA ϭ vestibular aqueduct; MRI IAM ϭ magnetic resonance imaging of internal acoustic meati; ED ϭ endolymphatic duct; ES ϭ endolymphatic sac; MAT ϭ mean auditory threshold. Progressive or stable hearing loss
Ears with no evidence of PHL n ϭ 13 n ϭ 24 n ϭ 20 n ϭ 20 n ϭ 19 3.5 (3.5) 2.6 (2.7) 3.9 (4.3) 14.2 (13.6) 4.9 (5.8)
Ears with PHL n ϭ 6 n ϭ 11 n ϭ 9 n ϭ 9 n ϭ 9 2.6 (2.7) 2.4 (2.5) 4.1 (4.4) 14.9 (15.7) 6.1 (8.9) Significant difference between means*
Sudden Drops in Hearing
Ears from patients with no history of sudden drops n ϭ 13 n ϭ 18 n ϭ 13 n ϭ 13 n ϭ 12 3.5 (3.5) 2.6 (2.7) 4.0 (4.5) 13.5 (13.2) 6.4 (6.2)
Ears from patients with a history of sudden drops n ϭ 6 n ϭ 17 n ϭ 16 n ϭ 16 n ϭ 16 2.6 (2. Ears from patients with Pendred Syndrome n ϭ 6 n ϭ 11 n ϭ 9 n ϭ 9 n ϭ 9 3.2 (3. EVA ϭ enlarged vestibular aqueduct; EED ϭ enlarged endolymphatic duct; EES ϭ enlarged endolymphatic sac; PS ϭ Pendred syndrome; NSEVAs ϭ non-syndromic enlarged vestibular aqueducts; CT PT ϭ computerized tomography of the petrous temporal bones; VA ϭ vestibular aqueduct; MRI IAM ϭ magnetic resonance imaging of the internal acoustic meati; ED ϭ endolymphatic duct; ES ϭ endolymphatic sac; PHL ϭ progressive hearing loss.
(3.5 to 1) is similar to previous studies that, taken together, found a mean ratio of 1.9 to 1. 2-8,13-16,20 -23 The prevalence of unilateral enlargements (15%) is similar to previous studies (mean, 23%). 2-6,8,13-16,20 -23 The average HL degree at the both the start and end of follow-up was severe, and previous studies have all reported moderate to severe HL. 5, 7, [13] [14] [15] [16] 21, 22 The proportion of ears with PHL (33%) corresponds to previous studies (mean, 32%). 7, 8, [13] [14] [15] [16] 22, 23 The mean rate of progression (3.0 dB per year) compares with 4 dB per year reported by Govaerts et al., 21 who also used regression analysis to estimate progression. The current study is unique in its attempt to control for the confounding influence of CSOME. Given that 90% of children develop CSOME by the age of 5 years, and it is recurrent in 40%, this is likely to be a significant confounding factor in any pediatric longitudinal study of hearing. 24 Sudden drops are a well recognized feature of EVArelated HL. However, as this study demonstrates, only a third of patients report sudden drops. When reported, they are usually triggered by minor head trauma but can be spontaneous. Other less commonly reported triggers include coryzal illness, exercise, plane travel, and playing a wind instrument. 6, [21] [22] [23] A mean sudden drop frequency of 0.2 per year (range 0 -1.5) and mean drop amplitude of 27 (range, 15-47) dB has been reported. 16 This study provides the first evidence of an association between sudden drops and PHL. This may have important implications for counseling of EVA patients.
A high prevalence of a low-frequency NACC to the HL has been reported previously, with three studies reporting 100%, 75%, and 90%, respectively. 12,14,21 Sato et al. 12 reported average air-bone gaps of 25 dB at 500 Hz and 20 dB at 1,000 Hz. These findings are in agreement with the current study (Table VII) .
This study provides the first evidence that a PS diagnosis may be associated with a more severe audiologic phenotype. PS patients had greater HL at the end of follow-up and were more likely to have sudden drops. No association between PS and PHL was found, but this may relate to small sample sizes. This is because not all patients had undergone SLC26A4 testing or a PDT. A number of studies have found that monoallelic SLC26A4 mutations are common, but not ubiquitous, in NSEVAs patients. 11, 25, 26 Further studies are required to clarify the SLC26A4 genotype/phenotype relationship.
The mean MMD on CT PT found in this study (3.2 mm) is in line with previous studies that have reported a mean MMD of between 2.3 and 3.7 mm (mean across the studies, 2.9 mm). 2,14,16,27,28 Dahlen et al. 2 measured the ED MMD with MRI and reported a mean of 3.8 mm, which is larger than the current study mean (2.6 mm). However, unlike the current study, Dahlen et al. noted a significant difference in mean CT and MRI MMD for ears that had been imaged with both modalities, with the MRI mean being greater. MRI has been validated as a tool to measure the ED by Kobayashi et al., 29 who demonstrated accurate agreement between MRI and histopathologic ED measurements in cadaveric temporal bones. MRI measurements of the EES maximum anteroposterior and transverse diameters have not been previously described, but Naganawa at al. 30 have used multiple cross-sectional ). The study proportion of patients with additional inner ear abnormalities (22%) is small when compared with previous studies, but there is marked variability in the reported prevalence in the EVA literature (range, 38 -100%; mean, 68%). 4 -6,8,10,14,15,20,31,32 However, deficiency of the interscalar septum between the cochlear apical and middle turns and a dilated vestibule are most commonly reported. Importantly, three EVA studies that have prospectively studied the cochlear modiolus with highresolution imaging have found a high prevalence of modiolar abnormalities (mean proportion, 90%). 10, 14, 32 The modiolus is a small cochlear component that is difficult to visualize using standard resolution imaging. It is therefore rarely commented on in routine clinical imaging and not discussed in the majority of EVA studies. Future studies should include high-resolution imaging to help clarify the true prevalence of additional inner ear abnormalities.
This study did not find evidence of a relationship between the EVA, EED, or EES dimensions and the history, degree, or progression of HL. Three studies have similarly found no relationship between the EVA dimensions and degree of HL. 7, 11, 27 One study reported that hearing thresholds were significantly correlated with MMD, but correlation coefficients are not given in the paper. 14 Madden et al. 7 reported that patients with PHL had a greater mean EVA external aperture diameter (EAD) as compared with those with stable or fluctuating HL. Our experience is that the VA EAD is difficult to measure on CT PT because of a lack of defined landmarks for the aperture edges. This has led to significant interinvestigator EAD measurement variability in our center, and four previous EVA studies have reported highly variable mean EADs (2.2 mm, 3.3 mm, 7.0 mm, and 5.6 mm, respectively). 7, 16, 22, 23 Lai and Shiao 16 reported that a larger MMD was associated with a greater frequency of sudden drops and that a larger EAD was associated with larger amplitude drops but did not describe the statistical methodology underlying these findings.
The pathophysiology of EVA-related HL is not known. However, the absence of any relationship between the HL and the degree of enlargement of the endolymphatic system in combination with a likely high prevalence of concomitant cochlear dysmorphology would suggest that the HL may be primarily related to cochlear dysmorphology as opposed to a direct effect of the enlarged endolymphatic system. The mechanism underlying the sudden drops in hearing has been the subject of much discussion in the literature, particularly with regard to the relationship with minor head trauma. Figure 5 summarizes the various proposed mechanisms.
CONCLUSION
EVAs are associated with a mixed, but predominantly sensorineural, HL of any degree. HL is typically severe and is progressive in a third of cases. Sudden drops in hearing are reported by a third of patients and are a risk factor for PHL. Patients and their families should therefore be counseled to avoid situations in which the patient is at an increased risk of minor head trauma (e.g., contact sports). It is likely that PS is associated with a worse audiologic prognosis than NSEVAs. There is no evidence that the degree of enlargement of the endolymphatic system is related to the degree or prognosis of HL.
